Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis

BACKGROUND: It remains controversial whether the platelet to lymphocyte ratio (PLR) serves as a potential indicator for the efficacy of immunotherapy in advanced lung cancer. This meta-analysis aimed to address this concern. METHODS: Up to March 2022, we searched PubMed, Embase, Web of Science and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ke, Cao, Jie, Lin, Huahang, Liang, Linchuan, Shen, Zhongzhong, Wang, Lei, Peng, Zhiyu, Mei, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437586/
https://www.ncbi.nlm.nih.gov/pubmed/36059629
http://dx.doi.org/10.3389/fonc.2022.962173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437586/
https://www.ncbi.nlm.nih.gov/pubmed/36059629
http://dx.doi.org/10.3389/fonc.2022.962173

Ejemplares similares